Panagora Asset Management Inc Teva Pharmaceutical Industries LTD Transaction History

Panagora Asset Management Inc

  • $19.7 Billion
  • Q2 2024

A detailed history of Panagora Asset Management Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Panagora Asset Management Inc holds 125,270 shares of TEVA stock, worth $2.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
125,270
Previous 415,404 69.84%
Holding current value
$2.14 Million
Previous $5.86 Million 65.28%
% of portfolio
0.01%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
$12.78 - $17.4 $3.71 Million - $5.05 Million
-290,134 Reduced 69.84%
125,270 $2.04 Million
Q1 2024

May 07, 2024
SELL
$10.67 - $14.43 $872,784 - $1.18 Million
-81,798 Reduced 16.45%
415,404 $5.86 Million
Q4 2023

Feb 08, 2024
BUY
$8.12 - $10.63 $3.04 Million - $3.98 Million
374,561 Added 305.41%
497,202 $5.19 Million
Q3 2023

Oct 31, 2023
SELL
$7.48 - $10.7 $319,022 - $456,354
-42,650 Reduced 25.8%
122,641 $1.25 Million
Q2 2023

Aug 11, 2023
BUY
$7.2 - $9.47 $97,560 - $128,318
13,550 Added 8.93%
165,291 $1.24 Million
Q1 2023

May 11, 2023
SELL
$8.36 - $11.37 $677,561 - $921,515
-81,048 Reduced 34.82%
151,741 $1.34 Million
Q4 2022

Feb 13, 2023
SELL
$7.95 - $9.48 $2.98 Million - $3.56 Million
-375,401 Reduced 61.72%
232,789 $2.12 Million
Q3 2022

Nov 14, 2022
SELL
$6.86 - $11.95 $4.92 Million - $8.57 Million
-717,473 Reduced 54.12%
608,190 $4.91 Million
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $8.16 Million - $11.5 Million
1,105,375 Added 501.79%
1,325,663 $9.97 Million
Q1 2022

May 12, 2022
BUY
$7.33 - $9.39 $913,156 - $1.17 Million
124,578 Added 130.16%
220,288 $2.07 Million
Q3 2021

Nov 10, 2021
SELL
$8.38 - $10.18 $13,156 - $15,982
-1,570 Reduced 1.61%
95,710 $932,000
Q2 2021

Aug 11, 2021
SELL
$9.9 - $11.56 $33,006 - $38,541
-3,334 Reduced 3.31%
97,280 $963,000
Q1 2021

May 12, 2021
SELL
$10.34 - $12.81 $40,408 - $50,061
-3,908 Reduced 3.74%
100,614 $1.16 Million
Q4 2020

Feb 10, 2021
SELL
$8.61 - $11.04 $655,935 - $841,060
-76,183 Reduced 42.16%
104,522 $1.01 Million
Q3 2020

Nov 13, 2020
BUY
$8.57 - $12.69 $189,259 - $280,245
22,084 Added 13.92%
180,705 $1.63 Million
Q2 2020

Aug 12, 2020
SELL
$8.12 - $13.12 $180,312 - $291,342
-22,206 Reduced 12.28%
158,621 $1.96 Million
Q1 2020

May 14, 2020
SELL
$6.69 - $13.45 $88,448 - $177,822
-13,221 Reduced 6.81%
180,827 $1.62 Million
Q4 2019

Feb 12, 2020
SELL
$6.53 - $10.72 $307,354 - $504,568
-47,068 Reduced 19.52%
194,048 $1.9 Million
Q3 2019

Nov 12, 2019
BUY
$6.16 - $9.6 $17,599 - $27,427
2,857 Added 1.2%
241,116 $1.66 Million
Q2 2019

Aug 09, 2019
SELL
$8.12 - $15.72 $5,927 - $11,475
-730 Reduced 0.31%
238,259 $2.2 Million
Q1 2019

May 15, 2019
SELL
$15.58 - $20.01 $1.85 Million - $2.37 Million
-118,490 Reduced 33.15%
238,989 $3.75 Million
Q4 2018

Feb 14, 2019
SELL
$14.59 - $23.84 $662,458 - $1.08 Million
-45,405 Reduced 11.27%
357,479 $5.51 Million
Q3 2018

Nov 13, 2018
BUY
$21.06 - $25.65 $2.71 Million - $3.3 Million
128,792 Added 46.99%
402,884 $8.68 Million
Q2 2018

Aug 14, 2018
SELL
$16.77 - $24.71 $290,590 - $428,174
-17,328 Reduced 5.95%
274,092 $6.67 Million
Q1 2018

May 15, 2018
SELL
$16.68 - $22.07 $327,511 - $433,344
-19,635 Reduced 6.31%
291,420 $4.98 Million
Q4 2017

Feb 14, 2018
BUY
$11.23 - $19.1 $2.94 Million - $5 Million
261,658 Added 529.7%
311,055 $5.89 Million
Q3 2017

Nov 14, 2017
BUY
$15.41 - $32.17 $761,207 - $1.59 Million
49,397
49,397 $869,000

Others Institutions Holding TEVA

# of Institutions
624
Shares Held
565M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email